Ceftobiprole medocaril

Zevtera

BrazilAuthorisedAuthorised 27 Jun 2022

In other countries

The same active substances on other registers, the same brand first.

ZevteraCanada · 500 MG / VIAL · Powder For Solution · Avir Pharma INC.Same brand
Zevtera 500 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 666.6 mg · polvo para concentrado para solución para perfusión · Advanz Pharma LimitedSame brand
ZEVTERA 500 mg Powder for concentration for Solution for InfusionSaudi Arabia · Nipro Pharma Corporation Ise PlantSame brand
ZevteraUnited States · 667MG/VIAL · powder · IstxSame brand
Zeftera (previously Zevtera)European Union · Janssen-Cilag International NVSame form
ZefteraCanada · 500 MG / VIAL · Powder For Solution · Janssen INCSame substance
Mabelio

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ceftobiprole medocaril

Zevtera

BrazilAuthorisedAuthorised 27 Jun 2022

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Italy · Polvere per concentrato per soluzione per infusione · Advanz Pharma Limited

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ceftobiprole medocaril
Register: Brazil (Anvisa)
Status: Authorised
Status in the register: Ativo
Authorised: 27 Jun 2022
Registration: 125760035
Marketing authorisation holder: United Medical Ltda
Procedure: Registered